Crown LiquidationCo NV in liquidatie CNTGF 上一季度的收入表現如何?
Crown LiquidationCo NV in liquidatie 的收入預期是多少?
Crown LiquidationCo NV in liquidatie 的盈利品質評分是多少?
Crown LiquidationCo NV in liquidatie 何時發布財報?
Crown LiquidationCo NV in liquidatie 的預期收益是多少?
Crown LiquidationCo NV in liquidatie 是否超出收益預期?
關鍵數據
前收市價
$0.1151
開盤價
$0.105
當日範圍
$0.105 - $0.105
52週區間
$0.01 - $0.705
交易量
--
平均成交量
1.0K
每股盈餘 (TTM)
-2.14
股息收益率
--
市值
$2.8M
什麼是 CNTGF?
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company is headquartered in Rostock, Mecklenburg-Vorpommern and currently employs 493 full-time employees. The company went IPO on 2019-11-07. The firm focuses on rare diseases, transforming clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The firm's platform includes epidemiological, phenotypic, and genetic data reflecting a global population, as well as a biobank of blood samples from these patients. The firm's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The firm's Clinical Diagnostics segment provides targeted genetic sequencing and diagnostic services to patients through its distribution partners and customers, which are typically physicians, laboratories or hospitals.